Original Research
Published on 15 Nov 2024
Discovery of novel and highly potent dual-targeting PKMYT1/HDAC2 inhibitors for hepatocellular carcinoma through structure-based virtual screening and biological evaluation
in Experimental Pharmacology and Drug Discovery